Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...] …
Category: Regulatory
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
HHS and Congress should each take long-proposed actions—including a contentious action to curb certain Part B prescribing incentives—to better ensure [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Supreme Court this week agreed to take on a case that potentially could expand the number of hospitals [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Five drugmakers have issued recent refund notices to 340B covered entities for drug overcharges. In letters posted on the website [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The federal office tasked with overseeing the 340B program will brief covered entities and manufacturers next week on the administrative [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal regulators said they were dropping from consideration a proposal for “stacking” discounts as part of an update to Medicaid [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The first fiscal year 2024 340B provider audit reports included no adverse findings for 19 organizations. The May 8 audit [...] …